MIT: Study Suggests New Molecular Strategy for Treating Fragile X Syndrome
March 05, 2025
March 05, 2025
CAMBRIDGE, Massachusetts, March 5 -- The Massachusetts Institute of Technology issued the following news:
* * *
Study suggests new molecular strategy for treating fragile X syndrome
Enhancing activity of a specific component of neurons' "NMDA" receptors normalized protein synthesis, neural activity, and seizure susceptibility in the hippocampus of fragile X lab mice.
By David Orenstein, The Picower Institute for Learning and Memo . . .
* * *
Study suggests new molecular strategy for treating fragile X syndrome
Enhancing activity of a specific component of neurons' "NMDA" receptors normalized protein synthesis, neural activity, and seizure susceptibility in the hippocampus of fragile X lab mice.
By David Orenstein, The Picower Institute for Learning and Memo . . .